HuagongsheHuagongshe Chemistry Print Report · For research reference only
HCID 86675689, compound → 5-(4-Methanesulfonyl-phenyl)-2-methyl-2-[1-(3-propyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]-2,3-dihydro-furo[2,3-c]pyridine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | HCID 86675689 | HCID 86675689 | — |
| Reactant | HCID 178449909 | HCID 178449909 | — |
| Product | 5-(4-Methanesulfonyl-phenyl)-2-methyl-2-[1-(3-propyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]-2,3-dihydro-furo[2,3-c]pyridine | HCID 78036783 | — |
Reaction Steps
The title compound is prepared from (S)-4-[5-(4-methanesulfonyl-phenyl)-2-methyl-2,3-dihydro-furo[2,3-c]pyridin-2-yl]-piperidine-1-carbonitrile (Intermediate 33; the configuration of the stereocenter is arbitrarily assigned) and N-hydroxy-butyramidine following a procedure analogous to that described in Example 2. LC (method 6): tR=1.25 min; Mass spectrum (ESI+): m/z=483 [M+H]+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08778926B2 |
| Source dataset | uspto-grants-2014_07 |
| ORD ID | ord-363690f57bb344d6ae668196c2841c21 |
| Source note | uspto-grants-2014_07 |